Genetic treatment of lung cancer: Is Trojan horse still valid?

Dohun Kim1, Su-Ryon Shin2, Jieun Jeon2, Ha-Yeon Byun2 1. Department of Thoracic and Cardiovascular surgery, College of Medicine, Chungbuk National University and Hospital, Cheongju, Korea 2. Harvard Medical School, Division of Engineering in Medicine, Brigham and Women’s Hospital, Cambridge, MA, US

첨부파일 : Genetic drug_Exo.pdf

책임저자: 김도훈

충북대학교

발표자: 김도훈, E-mail : mwille@chungbuk.ac.kr